Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
agonist, arm, assistance, Biological, building, Capvaxive, CDC, CID, Cipla, Civil, coformulation, compliance, County, curative, degeneration, diabetic, director, DMC, edema, endpoint, entirety, EyeBio, Eyebiotech, fully, futility, highly, inspection, IPR, leakage, Los, macular, malignant, mutual, neovascular, NMPA, official, opevesostat, pathway, pendency, pertaining, pleural, provisional, PTAB, Rebate, registered, Regulation, rendered, repayment, retinal, ship, Steglatro, tetravalent, tulisokibart, unanimously, unblinding, unconditionally, unexercised, unrecognized, vascular, vibostolimab, vision, Zhifei
Removed:
alleging, appealed, Beach, Breakthrough, Centene, closing, coupled, defrauded, denied, direct, Dohme, Eastern, falsifying, Foundation, fraud, Humana, indirect, Insurer, involvement, Kaiser, LLC, making, MDL, misrepresented, moot, moved, MSP, participate, Pennsylvania, proceed, prosecution, pursuing, putative, Rebecca, resolve, retailer, Schering, Sharp, Singapore, Smith, swine, unsealed, violation, Vytorin
Filing tables
Filing exhibits
Related press release
Associated MRK transcripts
MRK similar filings
Filing view
External links